Type 1 diabetes: open trials in United States

218 open trials have a site in United States. Registry data; only the trial team decides who can take part.

NCT07920341
Inter-Arm Differences in Continuous Glucose Monitor Readings in Adults With Diabetes
Trial Treatment · University of the Pacific
University of the Pacific, Stockton
Registry updated 2026-11-05
NCT07211802
CKM For Safe Use of SGLT2i in Type 1 Diabetes
Trial Treatment · Phase 3 · University of California, San Diego
UCSD - Altman Clinical & Translational Research Institute, La Jolla
Registry updated 2026-11-04
NCT07222137
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Trial Treatment · Phase 3 · Eli Lilly and Company
University of Virginia, Charlottesville · University of Iowa, Iowa City · Novak Center for Children's Health, Louisville · Children's Hospital of Philadelphia (CHOP), Philadelphia · Sansum Diabetes Research Institute, Santa Barbara · Tallahassee Memorial Healthcare, Tallahassee · Iowa Diabetes and Endocrinology Research Center, West Des Moines
Registry updated 2026-11-04
NCT07222332
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Trial Treatment · Phase 3 · Eli Lilly and Company
Barbara Davis Center for Childhood Diabetes, Aurora · University of Virginia, Charlottesville · Driscoll Children's Hospital, Corpus Christi · Children's Hospital of Philadelphia (CHOP), Philadelphia · Tallahassee Memorial Healthcare, Tallahassee
Registry updated 2026-11-04
NCT07807280
C-Carbs: A CGM-guided Approach to Teaching Carb Awareness
Trial Treatment · University of California, Los Angeles
University of California, Los Angeles, Los Angeles
Registry updated 2026-11-04
NCT07911033
Relationship Between Insulin Dose and Complications in Type 1 Diabetes
Research · Rachel Miller
University of Pittsburgh, Pittsburgh
Registry updated 2026-11-02
NCT06325202
Closed Loop and Education for Hypoglycemia Awareness Restoration
Trial Treatment · Milton S. Hershey Medical Center
University of California San Diego, La Jolla · University of Kentucky, Lexington · University of Minnesota, Minneapolis · AdventHealth, Orlando · University of Pennsylvania, Philadelphia
Registry updated 2026-10-30
NCT07720388
Supporting Medtronic 780G Insulin Pump Adoption in Latino Patients: A Spanish - Language Training Initiative
Trial Treatment · University of Colorado, Denver
Barbara Davis Center, Aurora
Registry updated 2026-10-30
NCT07784725
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Trial Treatment · Phase 3 · AstraZeneca
Ames · Arlington · Bridgeport · Butte · Champaign · Chicago · Clearwater · Columbus · Cortland · Dothan · El Dorado · Escondido · Fargo · Houston · Huntsville · Jacksonville · Jefferson City · Jersey City · Kansas City · Kingsport · Las Vegas · Maumee · Memphis · Mesa · Owensboro · Philadelphia · Portland · Renton · Rochester · Rocky Mount · Salt Lake City · San Antonio · Seattle · Smithfield · Statesville · Stockbridge · Sugar Land · Troy · Tulsa · Waco · Wilmington
Registry updated 2026-10-30
NCT06453928
Starting Technology in At Risk Type 1 Diabetes Study
Trial Treatment · University of California, Los Angeles
UCLA, Santa Monica · Olive View-UCLA Medical Center, Sylmar · Harbor-UCLA Medical Center, Torrance
Registry updated 2026-10-29
NCT07904793
Care COMPASS Study
Trial Treatment · Fitbit LLC
Oregon Health Sciences University, Portland
Registry updated 2026-10-29
NCT01793168
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Research · Sanford Health
Sanford Health, Sioux Falls
Registry updated 2026-10-28
NCT05641753
Cholesterol Lowering and Residual Risk in Diabetes, Type 1
Trial Treatment · Phase 4 · NYU Langone Health
NYU Langone Health, New York · NYC Health + Hospitals / Bellevue, New York · New York VA Hospital, New York · Mount Sinai School of Medicine, New York
Registry updated 2026-10-28
NCT07059806
T1CARE: A Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 Diabetes
Trial Treatment · Yale University
Yale Children's Diabetes Center, New Haven · Yale Adult Diabetes Center, New Haven
Registry updated 2026-10-26
NCT03585153
Multicenter Assessment of the Pancreas in Type 1 Diabetes
Research · Vanderbilt University Medical Center
University of Colorado, Barbara Davis Center, Aurora · University of Texas at Austin, Dell Medical School, Austin · University of Chicago, Kovler Diabetes Center, Chicago · Vanderbilt University Medical Center, Nashville
Registry updated 2026-10-23
NCT07325201
Mitigating DKA in Type 1 Diabetes for Safe Use of SGLT Inhibitors Using Dual Continuous Ketone and Glucose Monitoring.
Trial Treatment · Phase 2 · HealthPartners Institute
International Diabetes Center, Minneapolis
Registry updated 2026-10-23
NCT06516614
Sleep Coach for Adolescents With Type 1 Diabetes
Trial Treatment · Vanderbilt University Medical Center
Vanderbilt University Medical Center, Nashville
Registry updated 2026-10-21
NCT06524960
Denosumab for Type 1 Diabetes
Trial Treatment · Phase 1/2 · City of Hope Medical Center
University of Alabama at Birmingham, Birmingham · City of Hope Medical Center, Duarte · Indiana University, Indianapolis
Registry updated 2026-10-20
NCT06919354
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
Trial Treatment · Phase 1 · GentiBio, Inc
Joslin Diabetes Center, Boston · University of North Carolina at Chapel Hill, Chapel Hill · City of Hope Medical Center, Duarte · Duke University, Durham · University of Florida - Gainesville, Gainesville · University of Miami, Diabetes Research Institute, Miami · Columbia University, New York · Icahn School of Medicine at Mount Sinai, New York · University of California San Diego, San Diego · University of California San Francisco, San Francisco
Registry updated 2026-10-20
NCT07434544
Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D)
Trial Treatment · Medical College of Wisconsin
Medical College of Wisconsin, Milwaukee
Registry updated 2026-10-20
NCT07864168
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
Trial Treatment · Medtronic MiniMed, Inc.
Atlanta Diabetes Associates, Atlanta · Barbara Davis Center for Diabetes, Aurora · Texas Diabetes and Endocrinology, Austin · University of Virginia Health System, Charlottesville · ProSciento, Chula Vista · University of Florida, Gainesville · Rocky Mountain Clinical Research, Idaho Falls · Yale University School Of Medicine, New Haven · Stanford University, Palo Alto · Rainier Clinical Research Center, Renton · Diabetes and Glandular Disease Clinic, San Antonio · Rady Children's Hospital - San Diego, San Diego · University of California San Francisco UCSF The Madison Clinic for Pediatric Diabetes, San Francisco · Sansum Diabetes Research Institute, Santa Barbara · Seattle Children's, Seattle · University of South Florida (USF) Diabetes and Endocrinology Center, Tampa · Diablo Clinical Research, Inc., Walnut Creek
Registry updated 2026-10-20
NCT07881887
A Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 Diabetes
Trial Treatment · Phase 1 · Eli Lilly and Company
CenExel ACT, Anaheim · Ohio Clinical Trials, Columbus · Fortrea Clinical Research Unit, Dallas · Fortrea Clinical Research Unit, Daytona Beach · CenExel iResearch, LLC, Decatur · Collaborative Neuroscience Network - CNS, Los Alamitos · CenExel-HRI, Marlton · Advanced Pharma CR, LLC, Miami · Worldwide Clinical Trials, Inc., San Antonio · Diablo Clinical Research, Inc., Walnut Creek · Clinical Site Partners, LLC DBA CSP Orlando, Winter Park
Registry updated 2026-10-20
NCT06976619
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
Trial Treatment · Phase 2 · Mayo Clinic
Mayo Clinic in Rochester, Rochester
Registry updated 2026-10-19
NCT07061574
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Trial Treatment · Phase 1/2 · City of Hope Medical Center
University of Buffalo, Buffalo · University of Florida, Gainesville · Baylor College of Medicine, Houston · Indiana University, Indianapolis · UCLA, Los Angeles · University of Miami, Miami · University of Minnesota, Minneapolis · Yale University, New Haven · University of Pittsburgh, Pittsburgh · UCSF, San Francisco · Seattle Children's Hospital, Seattle
Registry updated 2026-10-16
NCT07676565
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
Research · Indiana University
Emory University, Atlanta · Harvard Medical School, Boston · Northwestern University, Chicago · University of Cincinnati, Cincinnati · Ohio State University, Columbus · Henry Ford Hospital, Detroit · University of Louisville, Louisville · University of Miami, Miami · HealthPartners, International Diabetes Center, Minneapolis · Hoag Memorial Hospital, Newport Beach · Mount Sinai, New York · NYU Grossman School of Medicine, New York · Eastern Virginia Medical Center, Old Dominion University, Norfolk · University of Nebraska Medical Center, Omaha · Maine Health Research Institute, Portland · University of Rochester, Rochester · University of California, San Francisco (UCSF), San Francisco
Registry updated 2026-10-16

All Type 1 diabetes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error